Clinical Trial Update: A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) [Phase 4]

View source ↗

Summary

A Phase 4 study assessed bone turnover markers in postmenopausal women with osteoporosis treated with monthly ibandronate (Boniva).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Boniva (ibandronate)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Post Menopausal Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2016-05-02